The occurrence of osteonecrosis (ON) in patients with systemic lupus erythematosus
(SLE) was first quantified by Dubois et al. [
[1]
] in 1960, in their report describing ON in 11 out of 400 SLE patients (2.8%). Newer
studies, with access to information on magnetic resonance imagining screening of the
lower limbs, have identified ON lesions in up to 37% of SLE patients [
[2]
] and in 44% of the hip and knee joints of SLE patients undergoing corticosteroid treatment
[
[3]
]. Moreover, in patients with ON taking corticosteroids, SLE appears to be the most
common underlying autoimmune disease [
2
,
4
].Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus.JAMA. 1960; 174: 966-971
- Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study.Rheumatology (Oxford). 2011; 50: 2023-2028
- Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.Lupus. 2010; 19: 1307-1314
- Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients.Chin Med J (Engl). 2013; 126: 290-295
- The Danish Civil Registration System as a tool in epidemiology.Eur J Epidemiol. 2014; 29: 541-549
- Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update.Arthritis Care Res. 1995; 8: 137-145
- LUMINA study group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study.Ann Rheum Dis. 2006; 65: 785-790
- Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.Lupus. 2014; 23: 39-45
- Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.Lupus. 2007; 16: 239-244
- Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.Clin Exp Rheumatol. 2010; 28: 13-18
Article Info
Publication History
Published online: July 14, 2016
Accepted:
July 7,
2016
Received:
July 5,
2016
Identification
Copyright
© 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
